Zimbabwe has turned down a major American health deal worth $367m (£272m) spanning five years due to Washington's request for sensitive biological samples.
This rejection came to light after a government memo dated December was disclosed, indicating that Head of State Emmerson Mnangagwa felt the agreement was "lopsided".
A government spokesperson later clarified that the United States was seeking genetic material for scientific study and commercial gain but was unwilling to guarantee the benefits from future vaccines.
"We will now turn to the difficult and regrettable task of winding down our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the United States had provided more than $1.9bn for health programmes to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has called for more negotiations to find a deal acceptable to all parties so the nation's critical HIV programme can proceed.
Wider Background
Zimbabwe's decision follows a similar case in neighbouring Kenya, where a court blocked a similar deal with the US following legal challenges were raised about the security of Kenyans' health data.
After resuming office recently, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
USAID had managed aid for the American government, but Trump argued its spending was "inefficient" and his administration was seeking direct bilateral agreements to boost openness and responsibility.
As per statements, Sixteen African countries have so far signed these new health pacts, constituting over $18.3bn of fresh investment.
Details of the Rejected Deal
This assistance for Zimbabwe was intended to supported "combating HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"We are confident this cooperation might have yielded significant advantages for the people of Zimbabwe, especially the 1.2 million presently on HIV treatment via US-supported initiatives," Tremont added.
However, official spokesman Nick Mangwana said the proposed deal was "unequal".
"The proposal required Zimbabwe to provide its biological resources and data over an extended period, without any corresponding assurance of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might be developed from that provided information," his statement read.
"Put simply, our nation would supply the basic resources for medical research with no assurance that the resulting innovations would be accessible to our population should a new pandemic emerge."
Sovereignty and International Frameworks
He also pointed out that the American exit from the World Health Organization (WHO) and its push of one-on-one deals were upending structures previously established via the global organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system created to deal with potential global health emergencies.
"This system is intended to ensure that when a country contributes its information, the benefits – including medicines and cures – are distributed fairly, not monopolised exclusively by those with the capability to develop them."
The government's concerns over the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We welcome further discussions with our US partners on how subsequent co-operation could be arranged in a manner that respects the sovereignty and interests of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the government's concerns, but urged that talks must proceed considering a large portion of the nation's Aids initiatives depended on external financing.
"If technical issues arise, such as those involving data governance or agreement terms, these can often be addressed through detailed discussion and mutually agreed protections," the group commented.
This impasse emphasises the complex tensions between receiving much-needed international aid and protecting local interests in an ever more interconnected world.